Paclitaxel and carboplatin versus mitoxantrone: Lessons of an underpowered study: Commentary Journal Article
| Author: | Morris, M. J. |
| Article Title: | Paclitaxel and carboplatin versus mitoxantrone: Lessons of an underpowered study: Commentary |
| Keywords: | cancer survival; overall survival; prednisone; clinical trial; cancer combination chemotherapy; drug efficacy; drug safety; monotherapy; paclitaxel; evidence based medicine; prostate specific antigen; carboplatin; quality of life; etoposide; neuropathy; granulocyte macrophage colony stimulating factor; docetaxel; cancer hormone therapy; drug response; mitoxantrone; cancer relapse; short survey; prostate adenocarcinoma; antiandrogen; castration; drug sensitivity; antineoplastic hormone agonists and antagonists; anaplastic carcinoma; bone disease; estramustine |
| Journal Title: | Nature Clinical Practice Oncology |
| Volume: | 3 |
| Issue: | 10 |
| ISSN: | 1743-4254 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2006-10-01 |
| Start Page: | 536 |
| End Page: | 537 |
| Language: | English |
| DOI: | 10.1038/ncponc0593 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 1" - "Export Date: 4 June 2012" - "Source: Scopus" |
